Fact CheckerSign in

NCT07411690Recruiting

Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

Cerebrospinal Fluid Leak Incidence, Management and Risk Factor After Supratentorial Craniotomy for Intracranial Tumors: a Prospective Observational Study.

Source: ClinicalTrials.gov · Last updated 22 May 2026

Brief summary (registry, in English)

Cerebrospinal fluid is a clear fluid that surrounds and protects the brain. During surgery for brain tumors, neurosurgeons often need to open the covering of the brain (the dura) to reach the tumor. At the end of the operation, this covering is carefully closed again. In some cases, the closure might not be completely adequate leading to cerebrospinal fluid leak. This leakage may collect under the scalp or flow out through the surgical wound. When this happens, the surgical wound may not heal properly, and the risk of infection can increase. These complications can delay recovery and may postpone additional treatments, such as radiotherapy or chemotherapy, that are often needed after brain tumor surgery. Although cerebrospinal fluid leakage is less common after supratentorial craniotomy (surgery on the upper part of the brain) than after other types of brain surgery, it remains a challenging complication and has not been well studied in this group of patients. The aim of this study is to determine how often cerebrospinal fluid leakage occurs after supratentorial craniotomy for intracranial tumors, identify factors that increase the risk of leakage, and evaluate how these leaks are managed. Understanding these factors may help reduce the occurrence of cerebrospinal fluid leakage and improve postoperative recovery in the future.

Status (registry)
Recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
8 Feb 2026
Start date
3 Feb 2026
Primary completion date
29 Feb 2028
Lead sponsor
Medical University of Warsaw
Diseases
Glioblastoma
NCT number
NCT07411690

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 3 Feb 2026 to the primary completion date, 29 Feb 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Revision surgery due to recurrent brain tumor

Other

  • Emergency neurosurgical procedure

Who the study is looking for

  • Male or female at least 18 years old
  • Qualified for a craniotomy due to supratentorial intracranial tumor

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Neurosurgery of Medical Univeristy of Warsaw
Coordinator of this site? Confirm its status
WarsawPolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.